Medicine and Health
Vaccination of SARS-CoV-2-infected individuals expands a broad range of clonally diverse affinity-matured B cell lineages
M. Chernychev, M. Sakharkar, et al.
This groundbreaking study reveals how vaccination of individuals previously infected with SARS-CoV-2 leads to intense and diverse antibody responses. Researchers isolated 459 spike-specific monoclonal antibodies, demonstrating their neutralizing ability against various viral variants, proving the efficacy of mRNA vaccines in enhancing immune response among convalescent individuals. Conducted by Mark Chernychev and colleagues.
~3 min • Beginner • English
Related Publications
Explore these studies to deepen your understanding of the subject.

